Indo-Bangla Pharmaceuticals Limited Board of Directors has recommended 4% Cash dividend (Excluding sponsor and Director) and 3% Stock Dividend for General Shareholders and ICB Excluding sponsors and Directors) for the year ended on June 30, 2021.